# Early Development Considerations for Innovative Combination Products:  Guidance for Industry  and FDA Staff - FDA Guidance Document

Source: https://www.globalkeysolutions.net/guidances/guidance-document/early-development-considerations-for-innovative-combination-products-guidance-for-industry-and-fda-staff/36676b52-57e2-4ab3-8bb5-0c933692434b

> FDA guidance document: Early Development Considerations for Innovative Combination Products:  Guidance for Industry  and FDA Staff. Issue date: September 01, 2006. Get complete insights and analysis.

---

## Details

- Title: Early Development Considerations for Innovative Combination Products:  Guidance for Industry  and FDA Staff
- Communication Type: Guidance Document
- Product Type: devices
- Office Name: Office of the Commissioner
- Office URL: /offices/office-of-the-commissioner/79483979-9582-427f-ac3d-46c715811424
- Issue Date: 2006-09-01
- Last Changed: 2021-05-13
- Docket Number: <a href="https://www.regulations.gov/docket/FDA-2020-D-1455">FDA-2020-D-1455</a>

## Related Documents

- [Submission and Resolution of Formal Disputes Regarding the Timeliness of Premarket Review of a Combination Product:  Guidance for Industry and FDA Staff](https://www.globalkeysolutions.net/guidances/guidance-document/submission-and-resolution-of-formal-disputes-regarding-the-timeliness-of-premarket-review-of-a-combination-product-guidance-for-industry-and-fda-staff/8d93e28c-9435-4a59-a96c-53b4bb7ae048)
- [New Contrast Imaging Indication Considerations for Devices and Approved Drug and Biological Products:  Guidance for Industry](https://www.globalkeysolutions.net/guidances/guidance-document/new-contrast-imaging-indication-considerations-for-devices-and-approved-drug-and-biological-products-guidance-for-industry/53827c26-7bc8-4348-a114-e4c7c1bb9ae2)
- [Technical Considerations for Pen, Jet, and Related Injectors Intended for Use with Drugs and Biological Products:  Guidance for Industry and FDA Staff](https://www.globalkeysolutions.net/guidances/guidance-document/technical-considerations-for-pen-jet-and-related-injectors-intended-for-use-with-drugs-and-biological-products-guidance-for-industry-and-fda-staff/ebb20b67-02d8-40a7-918e-388086ac1c10)